Schlessinger J - Search Results

1

Comparison of EGF receptor sequences as a guide to study the ligand binding site.

Avivi A, Lax I, Ullrich A, Schlessinger J, Givol D, Morse B. Avivi A, et al. Among authors: schlessinger j. Oncogene. 1991 Apr;6(4):673-6. Oncogene. 1991. PMID: 2030916

2

The binding of complement by complexes formed between a rabbit antibody and oligosaccharides of increasing size.

Jaton JC, Huser H, Riesen WF, Schlessinger J, Givol D. Jaton JC, et al. Among authors: schlessinger j. J Immunol. 1976 May;116(5):1363-6. J Immunol. 1976. PMID: 5560

3

Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity.

Tartare S, Ballotti R, Lammers R, Filloux C, Chauvel A, Schlessinger J, Ullrich A, Van Obberghen E. Tartare S, et al. Among authors: schlessinger j. J Cell Biol. 1992 Feb;116(3):627-33. doi: 10.1083/jcb.116.3.627. J Cell Biol. 1992. PMID: 1309816 Free PMC article.

4

Activation and regulation of the insulin receptor kinase.

Ballotti R, Baron V, Gautier N, Hainaut P, Scimeca JC, Dolais-Kitabgi J, Lammers R, Schlessinger J, Ullrich A, Van Obberghen E. Ballotti R, et al. Among authors: schlessinger j. Diabete Metab. 1992;18(1 Pt 2):98-103. Diabete Metab. 1992. PMID: 1314199 Review.

5

Presence of SH2 domains of phospholipase C gamma 1 enhances substrate phosphorylation by increasing the affinity toward the epidermal growth factor receptor.

Rotin D, Honegger AM, Margolis BL, Ullrich A, Schlessinger J. Rotin D, et al. Among authors: schlessinger j. J Biol Chem. 1992 May 15;267(14):9678-83. J Biol Chem. 1992. PMID: 1315766 Free article.

6

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J. Lowenstein EJ, et al. Among authors: schlessinger j. Cell. 1992 Aug 7;70(3):431-42. doi: 10.1016/0092-8674(92)90167-b. Cell. 1992. PMID: 1322798 Free article.

7

Growth factor signaling by receptor tyrosine kinases.

Schlessinger J, Ullrich A. Schlessinger J, et al. Neuron. 1992 Sep;9(3):383-91. doi: 10.1016/0896-6273(92)90177-f. Neuron. 1992. PMID: 1326293 Review. No abstract available.

8

The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.

Li W, Hu P, Skolnik EY, Ullrich A, Schlessinger J. Li W, et al. Among authors: schlessinger j. Mol Cell Biol. 1992 Dec;12(12):5824-33. doi: 10.1128/mcb.12.12.5824-5833.1992. Mol Cell Biol. 1992. PMID: 1333047 Free PMC article.

9

Role of SH2-containing proteins in cellular signaling by receptor tyrosine kinases.

Schlessinger J, Mohammadi M, Margolis B, Ullrich A. Schlessinger J, et al. Cold Spring Harb Symp Quant Biol. 1992;57:67-74. doi: 10.1101/sqb.1992.057.01.009. Cold Spring Harb Symp Quant Biol. 1992. PMID: 1339705 No abstract available.

10

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.

Redemann N, Holzmann B, von Rüden T, Wagner EF, Schlessinger J, Ullrich A. Redemann N, et al. Among authors: schlessinger j. Mol Cell Biol. 1992 Feb;12(2):491-8. doi: 10.1128/mcb.12.2.491-498.1992. Mol Cell Biol. 1992. PMID: 1346334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters